We are live on
!
Find out more
DAM
DLD Asset Management Portfolio holdings
AUM
$1.51B
Turnover
51.11%
1-Year Est. Return
5.32%
This Fund
S&P 500
This Quarter
Est. Return
+2.44%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$1.51B
AUM Growth
+$414M
(+38%)
Cap. Flow
-$406M
Cap. Flow
% of AUM
-26.85%
Top 10 Holdings %
Top 10 Hldgs %
44.89%
Holding
542
New
183
Increased
53
Reduced
33
Closed
94
Avg Time Held Equity + Options
0.3
years
Top 10 Avg Time Held Equity + Options
0.4
years
Top 20 Avg Time Held Equity + Options
0.4
years
Avg Time Held Equity only
0.3
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amkor Technology
AMKR
|
+$9.98M |
| 2 |
Aurora
AUR
|
+$9.24M |
| 3 |
Digital Realty Trust
DLR
|
+$6.7M |
| 4 |
Nouveau Monde Graphite
NMG
|
+$6.04M |
| 5 |
SILA
Sila Realty Trust
SILA
|
+$5.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medline Inc
MDLN
|
+$9.79M |
| 2 |
StandardAero Inc
SARO
|
+$7.75M |
| 3 |
CEPT
Cantor Equity Partners II
CEPT
|
+$7.19M |
| 4 |
MACOM Technology Solutions
MTSI
|
+$5.11M |
| 5 |
D. Boral Acquisition I Corp
DBCA
|
+$4.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 77.92% |
| 2 | Financials | 15.61% |
| 3 | Technology | 1.32% |
| 4 | Real Estate | 1.26% |
| 5 | Industrials | 1.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
CALL
Arrowhead Research
ARWR
$8.26B
| $408K | 0.03% |
+5,000
| New | +$369K |
2026 Q2
0 quarters
|
|
252
CSLM Digital Asset Acquisition Corp III
KOYN
$324M
| $406K | 0.03% |
40,000
| – | – |
2025 Q4
2 quarters
|
|
253
CALL
Viking Therapeutics
VKTX
$3.48B
| $390K | 0.03% |
+10,000
| New | +$323K |
2026 Q2
0 quarters
|
|
254
CALL
Acadia Pharmaceuticals
ACAD
$3.4B
| $380K | 0.03% |
+15,000
| New | +$330K |
2026 Q2
0 quarters
|
|
255
EGH Acquisition Corp
EGHA
$213M
| $378K | 0.03% |
36,717
+2,716
| +8% | +$27.9K |
2026 Q1
1 quarter
|
|
256
New Providence Acquisition Corp III
NPAC
$403M
| $365K | 0.02% |
35,196
-184,314
| -84% | -$1.9M |
2025 Q3
3 quarters
|
|
257
CALL
Annexon
ANNX
$682M
| $343K | 0.02% |
+60,000
| New | +$332K |
2026 Q2
0 quarters
|
|
|
BCARW
258
DELISTED
D. Boral ARC Acquisition I Corp Warrant
BCARW
| $327K | 0.02% |
180,709
+13,400
| +8% | +$19.6K |
2025 Q4
2 quarters
|
|
259
Toyota
TM
$226B
| $326K | 0.02% |
+1,934
| New | +$366K |
2026 Q2
0 quarters
|
|
260
FIGX Capital Acquisition Corp
FIGX
$200M
| $315K | 0.02% |
30,781
| – | – |
2025 Q3
3 quarters
|
|
261
Digital Asset Acquisition Corp
DAAQ
$241M
| $307K | 0.02% |
29,621
| – | – |
2025 Q3
3 quarters
|
|
262
MiMedx Group
MDXG
$683M
| $289K | 0.02% |
+75,000
| New | +$274K |
2026 Q2
0 quarters
|
|
263
PUT
Kymera Therapeutics
KYMR
$8.99B
| $287K | 0.02% |
+2,500
| New | +$215K |
2026 Q2
0 quarters
|
|
264
Insmed
INSM
$21.7B
| $267K | 0.02% |
+2,500
| New | +$303K |
2026 Q2
0 quarters
|
|
265
GSK
GSK
$98.2B
| $262K | 0.02% |
+5,000
| New | +$264K |
2026 Q2
0 quarters
|
|
266
Evernorth Holdings Inc. Class A Ordinary Shares
XRPN
$358M
| $261K | 0.02% |
25,000
-174,130
| -87% | -$1.81M |
2025 Q4
2 quarters
|
|
|
267
Acadia Pharmaceuticals
ACAD
$3.4B
| $253K | 0.02% |
+10,000
| New | +$220K |
2026 Q2
0 quarters
|
|
268
Gilead Sciences
GILD
$195B
| $253K | 0.02% |
+2,000
| New | +$264K |
2026 Q2
0 quarters
|
|
269
Yum China
YUMC
$15.1B
| $245K | 0.02% |
+6,000
| New | +$275K |
2026 Q2
0 quarters
|
|
270
PUT
Capricor Therapeutics
CAPR
$423M
| $241K | 0.02% |
+10,000
| New | +$303K |
2026 Q2
0 quarters
|
|
|
FACWW
271
Factorial Energy Inc Warrant
FACWW
$8.83M
| $227K | 0.02% |
167,208
+67,208
| +67% | +$87.9K |
2025 Q4
2 quarters
|
|
272
Disc Medicine
IRON
$2.17B
| $219K | 0.01% |
+3,000
| New | +$206K |
2026 Q2
0 quarters
|
|
273
Sanofi
SNY
$96.5B
| $213K | 0.01% |
+5,000
| New | +$223K |
2026 Q2
0 quarters
|
|
|
NHICW
274
DELISTED
NewHold Investment Corp III Warrants
NHICW
| $207K | 0.01% |
98,641
-45,929
| -32% | -$66.9K |
2025 Q4
2 quarters
|
|
|
CCIXW
275
DELISTED
Churchill Capital Corp IX Warrant
CCIXW
| $204K | 0.01% |
261,276
+81,995
| +46% | +$37.3K |
2025 Q4
2 quarters
|
|
Similar funds
FFM
AWA
SC
HCM
NB
WFA
RIM
AU
DLD Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, DLD Asset Management held 542 positions worth $1.51B, up 38% from $1.1B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
DLD Asset Management withdrew a net $406M in Q2 2026, closing 94 positions and reducing 33 holdings. Its most notable exit was Medline Inc, an estimated $9.79M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 78% of assets, up from 73% a quarter earlier, followed by Financials and Technology.
Against the trend, DLD Asset Management opened a new position in Amkor Technology worth $12.1M.
- DLD Asset Management's largest Q2 2026 buy was Amkor Technology: 140,000 shares worth $12.1M.
- DLD Asset Management added most to Norfolk Southern in Q2 2026, an estimated $4.48M increase.
- DLD Asset Management's biggest Q2 2026 reduction was D. Boral Acquisition I Corp, cutting an estimated $4.96M.
- DLD Asset Management fully exited Medline Inc in Q2 2026, selling an estimated $9.79M.
- DLD Asset Management's ten largest holdings make up 45% of its $1.51B portfolio in Q2 2026.
- DLD Asset Management opened 183 new positions and closed 94 in Q2 2026.
- DLD Asset Management's portfolio value rose 38% quarter-over-quarter to $1.51B.
Based on DLD Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.